The role of eosinophils in non-parasitic infections

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 11, Issue 2, 2011, Pages 165-172

  Linch, Stefanie N ^a   Gold, Jeffrey A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Bacteria; Eosinophils; Fungi; Granules; Toll like receptors; Viruses

Indexed keywords

CD11B ANTIGEN; CD63 ANTIGEN; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; FLAGELLIN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9;

ALTERNARIA ALTERNATA; ANTIBACTERIAL ACTIVITY; ANTIGEN PRESENTATION; ANTIVIRAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; CLOSTRIDIUM PERFRINGENS; CYTOKINE RELEASE; DEGRANULATION; EOSINOPHIL; ESCHERICHIA COLI; GRANULOCYTE FUNCTION; HAEMOPHILUS INFLUENZAE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INFECTION; LEUKOCYTE ACTIVATION; MICROORGANISM DETECTION; NON PARASITIC INFECTION; NONHUMAN; PARAINFLUENZA VIRUS; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; STAPHYLOCOCCUS AUREUS; TH1 CELL; TH2 CELL; VIRUS INFECTION;

EID: 79956287128     PISSN: 18715303     EISSN: 18715303     Source Type: Journal    
DOI: 10.2174/187153011795564188     Document Type: Article

References (58)

1. Rothenberg, M.E. and Hogan, S.P. (2006) The eosinophil. Annu. Rev. Immunol., 24, 147-174.
2. Calafat, J., Janssen, H., Tool, A., Dentener, M.A., Knol, E.F., Rosenberg, H. F. and Egesten, A. (1998) The bactericidal permeability-increasing protein (BPI) is present in specific granules of human eosinophils. Blood, 91(12), 4770-4775.
3. Driss, V., Legrand, F., Hermann, E., Loiseau, S., Guerardel, Y., Kremer, L., Adam, E., Woerly, G., Dombrowicz, D. and Capron, M. (2009) TLR2-dependent eosinophil interactions with mycobacteria: role of alpha-defensins. Blood, 113(14), 3235-3244.
4. Lopez, A.F., Begley, C.G., Williamson, D.J., Warren, D.J., Vadas, M.A. and Sanderson, C.J. (1986) Murine eosinophil differentiation factor. An eosinophil-specific colony-stimulating factor with activity for human cells. J. Exp. Med., 163(5), 1085-1099.
5. Lopez, A.F., Sanderson, C.J., Gamble, J.R., Campbell, H.D., Young, I.G. and Vadas, M.A. (1988) Recombinant human interleukin 5 is a selective activator of human eosinophil function. J. Exp. Med., 167(1), 219-224.
6. Rothenberg, M.E., Pomerantz, J.L., Owen, W.F.Jr., Avraham, S., Soberman, R.J., Austen, K.F. and Stevens, R.L. (1988) Characterization of a human eosinophil proteoglycan, and augmentation of its biosynthesis and size by interleukin 3, interleukin 5, and granulocyte/macrophage colony stimulating factor. J. Biol. Chem., 263(27), 13901-13908.
7. Sanderson, C.J. (1992) Interleukin-5, eosinophils, and disease. Blood, 79(12), 3101-3109.
8. Yamaguchi, Y., Hayashi, Y., Sugama, Y., Miura, Y., Kasahara, T., Kitamura, S., Torisu, M., Mita, S., Tominaga, A. and Takatsu, K. (1988) Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor. J. Exp. Med., 167(5), 1737-1742.
9. Collins, P.D., Marleau, S., Griffiths-Johnson, D.A., Jose, P.J. and Williams, T.J. (1995) Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J. Exp. Med., 182(4), 1169-1174.
10. Giembycz, M.A. and Lindsay, M.A. (1999) Pharmacology of the eosinophil. Pharmacol. Rev., 51(2), 213-340.
11. Hogan, S.P., Rosenberg, H.F., Moqbel, R., Phipps, S., Foster, P.S., Lacy, P., Kay, A.B. and Rothenberg, M.E. (2008) Eosinophils: biological properties and role in health and disease. Clin. Exp. Allergy, 38(5), 709-750.
12. Anthony, R.M., Rutitzky, L.I., Urban, J.F. Jr., Stadecker, M.J. and Gause, W.C. (2007) Protective immune mechanisms in helminth infection. Nat. Rev. Immunol., 7(12), 975-987.
13. Rosenberg, H.F. and Domachowske, J.B. (2001) Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens. J. Leukoc. Biol., 70(5), 691-698.
14. Plotz, S.G., Lentschat, A., Behrendt, H., Plotz, W., Hamann, L., Ring, J., Rietschel, E.T., Flad, H.D. and Ulmer, A.J. (2001) The interaction of human peripheral blood eosinophils with bacterial lipopolysaccharide is CD14 dependent. Blood, 97(1), 235-241.
15. Wong, C.K., Cheung, P.F., Ip, W.K. and Lam, C.W. (2007) Intracellular signaling mechanisms regulating toll-like receptormediated activation of eosinophils. Am. J. Respir. Cell. Mol. Biol., 37(1), 85-96.
16. Sabroe, I., Jones, E.C., Usher, L.R., Whyte, M.K. and Dower, S.K. (2002) Toll-like receptor (TLR)2 and TLR4 in human peripheral blood granulocytes: a critical role for monocytes in leukocyte lipopolysaccharide responses. J. Immunol., 168 (9), 4701-4710.
17. Mansson, A., Fransson, M., Adner, M., Benson, M., Uddman, R., Bjornsson, S. and Cardell, L.O. (2010) TLR3 in human eosinophils: functional effects and decreased expression during allergic rhinitis. Int. Arch. Allergy Immunol., 151(2), 118-128.
18. Nagase, H., Okugawa, S., Ota, Y., Yamaguchi, M., Tomizawa, H., Matsushima, K., Ohta, K., Yamamoto, K. and Hirai, K. (2003) Expression and function of Toll-like receptors in eosinophils: activation by Toll-like receptor 7 ligand. J. Immunol., 171(8), 3977-3982.
19. Kawai, T. and Akira, S. (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol., 11(5), 373-384.
20. Gilleron, M., Nigou, J., Nicolle, D., Quesniaux, V. and Puzo, G. (2006) The acylation state of mycobacterial lipomannans modulates innate immunity response through toll-like receptor 2. Chem. Biol., 13(1), 39-47.
21. Phipps, S., Lam, C.E., Mahalingam, S., Newhouse, M., Ramirez, R., Rosenberg, H.F., Foster, P.S. and Matthaei, K.I. (2007) Eosinophils contribute to innate antiviral immunity and promote clearance of respiratory syncytial virus. Blood, 110(5), 1578-1586.
22. Yazdanbakhsh, M., Eckmann, C.M., Koenderman, L., Verhoeven, A.J. and Roos, D. (1987) Eosinophils do respond to fMLP. Blood, 70(2), 379-383.
23. Svensson, L. and Wenneras, C. (2005) Human eosinophils selectively recognize and become activated by bacteria belonging to different taxonomic groups. Microbes Infect., 7(4), 720-728.
24. Yoon, J., Ponikau, J.U., Lawrence, C.B. and Kita, H. (2008) Innate antifungal immunity of human eosinophils mediated by a beta 2 integrin, CD11b. J. Immunol., 181(4), 2907-2915.
25. Yazdanbakhsh, M., Eckmann, C.M., Bot, A.A. and Roos, D. (1986) Bactericidal action of eosinophils from normal human blood. Infect. Immun., 53(1), 192-198.
26. Linch, S.N., Kelly, A.M., Danielson, E.T., Pero, R., Lee, J.J. and Gold, J.A. (2009) Mouse eosinophils possess potent antibacterial properties in vivo. Infect. Immun., 77(11), 4976-4982.
27. Wassom, D.L. and Gleich, G.J. (1979) Damage to Trichinella spiralis newborn larvae by eosinophil major basic protein. Am. J. Trop Med. Hyg., 28(5), 860-863.
28. Butterworth, A.E., Wassom, D.L., Gleich, G.J., Loegering, D.A. and David, J.R. (1979) Damage to schistosomula of Schistosoma mansoni induced directly by eosinophil major basic protein. J. Immunol., 122(1), 221-229.
29. McLaren, D.J., McKean, J.R., Olsson, I., Venges, P. and Kay, A.B. (1981) Morphological studies on the killing of schistosomula of Schistosoma mansoni by human eosinophil and neutrophil cationic proteins in vitro. Parasite Immunol., 3(4), 359-373.
30. Specht, S., Saeftel, M., Arndt, M., Endl, E., Dubben, B., Lee, N.A., Lee, J.J. and Hoerauf, A. (2006) Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection. Infect. Immun., 74(9), 5236-5243.
31. Persson, T., Andersson, P., Bodelsson, M., Laurell, M., Malm, J. and Egesten, A. (2001) Bactericidal activity of human eosinophilic granulocytes against Escherichia coli. Infect. Immun., 69(6), 3591-3596.
32. Lehrer, R.I., Szklarek, D., Barton, A., Ganz, T., Hamann, K.J. and Gleich, G.J. (1989) Antibacterial properties of eosinophil major basic protein and eosinophil cationic protein. J. Immunol., 142(12), 4428-4434.
33. Jong, E.C., Henderson, W.R. and Klebanoff, S.J. (1980) Bactericidal activity of eosinophil peroxidase. J. Immunol., 124(3), 1378-1382.
34. Watanabe, M., Nittoh, T., Suzuki, T., Kitoh, A., Mue, S. and Ohuchi, K. (1995) Isolation and partial characterization of eosinophil granule proteins in rats--eosinophil cationic protein and major basic protein. Int. Arch. Allergy Immunol., 108(1), 11-18.
35. Torrent, M., Navarro, S., Moussaoui, M., Nogues, M.V. and Boix, E. (2008) Eosinophil cationic protein high-affinity binding to bacteria-wall lipopolysaccharides and peptidoglycans. Biochemistry, 47(11), 3544-3555.
36. Torrent, M., de la Torre, B.G., Nogues, V.M., Andreu, D. and Boix, E. (2009) Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment. Biochem. J., 421(3), 425-434.
37. Wang, J. and Slungaard, A. (2006) Role of eosinophil peroxidase in host defense and disease pathology. Arch. Biochem. Biophys., 445(2), 256-260.
38. Wang, J.G., Mahmud, S.A., Thompson, J.A., Geng, J.G., Key, N.S. and Slungaard, A. (2006) The principal eosinophil peroxidase product, HOSCN, is a uniquely potent phagocyte oxidant inducer of endothelial cell tissue factor activity: a potential mechanism for thrombosis in eosinophilic inflammatory states. Blood, 107(2), 558-565.
39. Inoue, Y., Matsuwaki, Y., Shin, S.H., Ponikau, J.U. and Kita, H. (2005) Nonpathogenic, environmental fungi induce activation and degranulation of human eosinophils. J. Immunol., 175(8), 5439-5447.
40. White, S.H., Wimley, W.C. and Selsted, M.E. (1995) Structure, function, and membrane integration of defensins. Curr. Opin. Struct. Biol., 5(4), 521-527.
41. Yousefi, S., Gold, J.A., Andina, N., Lee, J.J., Kelly, A.M., Kozlowski, E., Schmid, I., Straumann, A., Reichenbach, J., Gleich, G.J. and Simon, H.U. (2008) Catapult-like release of mitochondrial DNA by eosinophils contributes to antibacterial defense. Nat. Med., 14(9), 949-953.
42. Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D.S., Weinrauch, Y. and Zychlinsky, A. (2004) Neutrophil extracellular traps kill bacteria. Science, 303(5663), 1532-1535.
43. Ahren, I.L., Eriksson, E., Egesten, A. and Riesbeck, K. (2003) Nontypeable Haemophilus influenzae activates human eosinophils through beta-glucan receptors. Am. J. Respir. Cell Mol. Biol., 29(5), 598-605.
44. Shi, H.Z. (2004) Eosinophils function as antigen-presenting cells. J. Leukoc. Biol., 76(3), 520-527.
45. Bashir, M.E., Louie, S., Shi, H.N. and Nagler-Anderson, C. (2004) Toll-like receptor 4 signaling by intestinal microbes influences susceptibility to food allergy. J. Immunol., 172(11), 6978-6987.
46. MacKenzie, J.R., Mattes, J., Dent, L.A. and Foster, P.S. (2001) Eosinophils promote allergic disease of the lung by regulating CD4(+) Th2 lymphocyte function. J. Immunol., 167(6), 3146-3155.
47. Handzel, Z.T., Busse, W.W., Sedgwick, J.B., Vrtis, R., Lee, W.M., Kelly, E.A. and Gern, J.E. (1998) Eosinophils bind rhinovirus and activate virus-specific T cells. J. Immunol., 160(3), 1279-1284.
48. Slifman, N.R., Loegering, D.A., McKean, D.J. and Gleich, G.J. (1986) Ribonuclease activity associated with human eosinophilderived neurotoxin and eosinophil cationic protein. J. Immunol., 137(9), 2913-2917.
49. Domachowske, J.B., Dyer, K.D., Adams, A.G., Leto, T.L. and Rosenberg, H.F. (1998) Eosinophil cationic protein/RNase 3 is another RNase A-family ribonuclease with direct antiviral activity. Nucleic Acids Res., 26(14), 3358-3363.
50. Youle, R.J., Wu, Y.N., Mikulski, S.M., Shogen, K., Hamilton, R.S., Newton, D., D'Alessio, G. and Gravell, M. (1994) RNase inhibition of human immunodeficiency virus infection of H9 cells. Proc. Natl. Acad. Sci. USA, 91(13), 6012-6016.
51. Saxena, S.K., Gravell, M., Wu, Y.N., Mikulski, S.M., Shogen, K., Ardelt, W. and Youle, R.J. (1996) Inhibition of HIV-1 production and selective degradation of viral RNA by an amphibianribonuclease. J. Biol. Chem., 271(34), 20783-20788.
52. Garofalo, R., Kimpen, J.L., Welliver, R.C. and Ogra, P.L. (1992) Eosinophil degranulation in the respiratory tract during naturally acquired respiratory syncytial virus infection. J. Pediatr., 120(1), 28-32.
53. Colocho Zelaya, E.A., Orvell, C. and Strannegard, O. (1994) Eosinophil cationic protein in nasopharyngeal secretions and serum of infants infected with respiratory syncytial virus. Pediatr. AllergyImmunol., 5(2), 100-106.
54. Domachowske, J.B., Dyer, K.D., Bonville, C.A. and Rosenberg, H.F. (1998) Recombinant human eosinophil-derived neurotoxin/RNase 2 functions as an effective antiviral agent against respiratory syncytial virus. J. Infect. Dis., 177(6), 1458-1464.
55. Olszewska-Pazdrak, B., Pazdrak, K., Ogra, P.L. and Garofalo, R.P. (1998) Respiratory syncytial virus-infected pulmonary epithelialcells induce eosinophil degranulation by a CD18-mediated mechanism. J. Immunol., 160(10), 4889-4895.
56. Klebanoff, S.J. and Coombs, R.W. (1996) Virucidal effect of stimulated eosinophils on human immunodeficiency virus type 1. AIDS Res. Hum. Retroviruses, 12(1), 25-29.
57. Adamko, D.J., Yost, B.L., Gleich, G.J., Fryer, A.D. and Jacoby, D.B. (1999) Ovalbumin sensitization changes the inflammatory response to subsequent parainfluenza infection. Eosinophils mediate airway hyperresponsiveness, m(2) muscarinic receptor dysfunction, and antiviral effects. J. Exp. Med., 190(10), 1465-1478.
58. Dyer, K.D., Percopo, C.M., Fischer, E.R., Gabryszewski, S.J. and Rosenberg, H.F. (2009) Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6. Blood, 114(13), 2649-2656.